Quick Answer
In the EGRIFTA SV label, tesamorelin is taken as a once-daily subcutaneous injection into the abdomen. The label lists 1.4 mg, or 0.35 mL of reconstituted solution, injected once daily. It also says to rotate abdominal injection sites and avoid scar tissue, bruises, and the navel.
The practical takeaway is that tesamorelin is a consistency peptide, not a casual once-in-a-while supplement. The clinical story around visceral-fat reduction comes from daily subcutaneous use over months, so the routine matters: correct format, correct reconstitution context, consistent administration, and clear separation between label dosing and research-vial math.
Explore the AminoRank tesamorelin profileReview linked studies, category details, and vendor availability for tesamorelin.View tesamorelin profileInjection Format
Tesamorelin is not an oral peptide in the evidence-backed product context. EGRIFTA SV is a lyophilized powder that is reconstituted and injected subcutaneously.
That matters because readers sometimes look for tablets, sprays, or shortcuts. The strongest source-backed format is injectable tesamorelin, and the strongest result data are tied to that format. If someone wants the evidence-backed tesamorelin story, injection is the format that carries it.
Where To Inject Tesamorelin
DailyMed says EGRIFTA SV is injected into the abdomen and that injection sites should be rotated. It also says not to inject into scar tissue, bruises, or the navel.
This is practical, not cosmetic. The abdomen is the studied label site, and rotation helps reduce irritation in the same patch of skin. Injection-site redness, itching, pain, irritation, and bruising are all label-relevant reactions, so site technique is part of tolerability rather than a minor detail.
| Label topic | Practical meaning |
|---|---|
| Route | Subcutaneous injection. |
| Site | Abdomen. |
| Rotation | Use different abdominal areas. |
| Avoid | Scar tissue, bruises, and navel. |
| Common site reactions | Redness, itching, pain, irritation, bruising. |
Reconstitution Context
The EGRIFTA SV label says to reconstitute one vial with 0.5 mL of the provided sterile water and mix by rolling gently, not shaking. It also says to administer 0.35 mL immediately after reconstitution and discard unused solution.
Research-vial math may look different because research listings can use different vial amounts and liquid volumes. That is why concentration should be calculated rather than assumed.
Use the peptide calculatorCalculate concentration and syringe-unit math for research planning.Open calculatorWhen To Take Tesamorelin
The label establishes once-daily administration. It does not make a dramatic claim that a specific clock time is the main driver of results. In practical terms, the bigger issue is consistency: a daily peptide protocol is easier to understand when timing is repeatable and the same administration steps are followed each time.
For clinical use, timing belongs with the prescriber and label instructions. For research planning, timing should not be confused with dose or concentration. Tesamorelin's reputation was built on repeated daily exposure and measured body-composition change, not on a magic hour of the day.
Best Time To Take Tesamorelin
People often ask about morning versus evening because tesamorelin is a GH-axis peptide. The strongest public label source does not make a reader-facing "best time" claim. That makes a universal morning-or-night answer weaker than it sounds.
The stronger answer is that tesamorelin is studied and labeled as a once-daily peptide, and the quality of the routine matters more than internet timing folklore. The impressive part of tesamorelin is not a timing trick. It is the sustained GH-axis signal and the published visceral-fat outcomes that followed repeated use.
Buying The Right Format
For research listings, the first format check is simple: is it actually lyophilized tesamorelin, and does the listing clearly show vial amount and supporting documentation? Administration details are only useful if the product itself is clearly labeled and easy to audit.
Tesamorelin Vendors With Documentation Signals
View all Tesamorelin vendors| Vendor | Country | COAs | Rating | Reviews | Notes | Website |
|---|---|---|---|---|---|---|
| LA Peptides | USA | Yes | 5.0 | 1 | Verified listing | Buy |
| NextGenPeps | USA | Yes | 5.0 | 1 | Verified listing | Buy |
| Alpha Peptides | USA | Yes | 0.0 | 0 | Verified listing | Buy |
| Ascension Peptides | USA | Yes | 0.0 | 0 | Verified listing | Buy |
| BioCollex | USA | Yes | 0.0 | 0 | Verified listing | Buy |
| Coastal Peptides | USA | Yes | 0.0 | 0 | Verified listing | Buy |
FAQ
Is tesamorelin injected or oral?
Tesamorelin's evidence-backed product context is injectable, not oral.
Can tesamorelin be injected anywhere?
The EGRIFTA SV label says abdomen and rotating sites. It also says to avoid scar tissue, bruises, and the navel.
Do you shake tesamorelin after reconstitution?
The EGRIFTA SV label says to mix by rolling the vial gently and not to shake.
Is timing more important than dose?
No. Timing, dose, formulation, and administration are different issues. The label establishes once-daily use.